Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed, signaling no participant enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), updates the revision label to v3.6.0, and adjusts the Intervention/Treatment header formatting.
    Difference
    0.4%
    Check dated 2026-06-14T00:56:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page is now live. This appears to be a metadata/maintenance update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-06-06T23:23:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page framework without changes to study content.
    Difference
    0.1%
    Check dated 2026-05-16T10:26:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site release.
    Difference
    0.1%
    Check dated 2026-04-25T06:02:50.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:56:07.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The condition name was changed from 'Neuroendocrine pancreatic tumor' to 'Neuroendocrine tumor of pancreas' in the study's conditions section.
    Difference
    0.1%
    Check dated 2026-03-27T13:28:44.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.